IMMIX BIOPHARMA, INC. (IMMX) Operating cash flow 2020–2025
IMMIX BIOPHARMA, INC. (IMMX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$23.9MFY2025 · since FY2020: -$404,694 → -$23.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.9M | -64.0% |
| FY2024 | -$14.6M | -28.3% |
| FY2023 | -$11.4M | -53.5% |
| FY2022 | -$7.4M | -366.1% |
| FY2021 | -$1.6M | -292.7% |
| FY2020 | -$404,694 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IMMX financial trends
IMMX RevenueIMMX Net incomeIMMX Net marginIMMX Gross profitIMMX Gross marginIMMX Operating incomeIMMX Operating marginIMMX Free cash flowIMMX Capital expendituresIMMX Return on equityIMMX Stock buybacksIMMX Dividends paidIMMX Total assetsIMMX Total liabilitiesIMMX Shareholders’ equityIMMX overview →